# Astellas Pharma Europe B.V.

Organization · id `cardio:org-astellas-pharma-europe-b-v` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Astellas+Pharma+Europe+B.V.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Astellas Pharma Europe B.V.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis (`cardio:ct-nct01750190`)
- Sponsors: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis (`cardio:ct-nct01887600`)
- Sponsors: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa (`cardio:ct-nct02021318`)
- Sponsors: Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants (`cardio:ct-nct02052310`)
- Sponsors: Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis (`cardio:ct-nct02273726`)
- Sponsors: Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis (`cardio:ct-nct02278341`)
- Sponsors: A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease (`cardio:ct-nct02358096`)
- Sponsors: A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin (`cardio:ct-nct02794792`)

## Provenance

Content hash: b650fe6685784ecf8792977cc49a2b2e89ff2d1b970ab97fa05a6cd92d678495
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
